Alan Budney, PhD
Professor, Geisel School of Medicine at Dartmouth
Alan Budney is a Professor at the Geisel School of Medicine at Dartmouth and Director of the T32 Predoctoral and Postdoctoral Training Program in the Science of Co-occurring Disorders. He received his PhD in Clinical Psychology from Rutgers University and did his postdoctoral training at the University of Vermont. He has conducted extensive research on the development and evaluation of innovative behavioral treatments for Cannabis Use Disorders in adults and adolescents. This programmatic research has focused on integrating innovative contingency management interventions with more traditional behavioral therapies and using computer-assisted therapies to enhance access to and the cost effectiveness of these approaches. He has also conducted human laboratory and survey studies characterizing cannabis use and withdrawal. His recent work leverages social media enrollment strategies to assess the impact of the changing legal landscape of cannabis, to develop on-line interventions for cannabis use problems, and to develop methods for accurately measuring cannabis consumption to inform more meaningful public health messaging about the potential negative and positive consequences of cannabis use. Dr. Budney was President of Division 28 and Division 50 of the American Psychological Association and the College on Problems of Drug Dependence. He was a member of the DSM-5 Substance Use Disorders working group and has served on numerous scientific reviews at the NIH and other institutions. He is currently on the Scientific Advisory Board of the Center for Medical Cannabis Research at the University of California San Diego. Dr. Budney has also been an active member of many community task forces targeting reduction in delinquency, violence, and substance use problems.
Dr. Budney is an avid sports fan and enjoys the theatre. He will play golf with anyone interested whenever possible, enjoys downhill skiing when not injured, and would love to BBQ if you’d like to stop by his home in Charlotte, VT.
Selected Publications
- Fontana TJK, Schulz JA, Budney AJ, Villanti AC. Feasibility and utility of a structured guide for cannabis tolerance breaks in young adults. J Am Coll Health. 2025 Jan;73(1):5-9. doi: 10.1080/07448481.2022.2155061. PMID: 36595624; PMCID: PMC10315416.
- Budney AJ, Borodovsky JT, Struble CA, Habib MI, Shmulewitz D, Livne O, Aharonovich E, Walsh C, Cuttler C, Hasin DS. Estimating THC consumption from smoked and vaped cannabis products in an online survey of adults who use cannabis. Cannabis Cannabinoid Res. 2024 Apr;9(2):688-698. doi: 10.1089/can.2022.0238. PMID: 36521175; PMCID: PMC10998014.
- Borodovsky JT, Hasin DS, Shmulewitz D, Walsh C, Livne O, Aharonovich E, Struble CA, Habib MI, Budney AJ. Typical hits, grams, or joints: Evaluating cannabis survey measurement strategies for quantifying consumption. Cannabis Cannabinoid Res. 2024 Apr;9(2):646-658. doi: 10.1089/can.2022.0237. PMID: 36577020; PMCID: PMC10998027.
- Shmulewitz D, Budney AJ, Borodovsky JT, Bujno JM, Walsh CA, Struble CA, Livne O, Habib MI, Aharonovich E, Hasin DS. Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use. J Psychiatr Res. 2023 Jul;163:211-221. doi: 10.1016/j.jpsychires.2023.05.048. PMID: 37224773.
- Hasin DS, Borodovsky J, Shmulewitz D, Walsh C, Struble CA, Livne O, Habib MI, Fink DS, Aharonovich E, Budney A. Adult use of highly-potent Δ9-THC cannabis concentrate products by U.S. state cannabis legalization status, 2021. Addict Behav. 2023 May;140:107617. doi: 10.1016/j.addbeh.2023.107617. PMID: 36736229; PMCID: PMC9930475.
- Walsh CA, Struble CA, Aharonovich E, Shmulewitz D, Borodovsky J, Habib MI, Budney A, Livne O, Hasin DS. Evaluating cannabis exposure in survey items: Insights, strategies, and remaining challenges identified from cognitive interviewing. Drug Alcohol Depend Rep. 2023 Apr 19;7:100161. doi: 10.1016/j.dadr.2023.100161. PMID: 37179574; PMCID: PMC10173391.
- Tackett AP, Wong M, Cho J, Harlow AF, Vogel EA, Han DH, Barrington-Trimis JL, McConnell R, Budney AJ, Audrain-McGovern JE, Lerman C, Monterosso J, Leventhal AM. Willingness to use commercial nicotine gums, lozenges, and gummies among nontobacco using adolescents in Southern California. J Adolesc Health. 2023 Feb;72(2):277-286. doi: 10.1016/j.jadohealth.2022.09.027. PMID: 36470691.
- Anderson MA, Budney AJ, Jacobson NC, Nahum-Shani I, Stanger C. End user participation in the development of an ecological momentary intervention to improve coping with cannabis cravings: Formative study. JMIR Form Res. 2022 Dec 15;6(12):e40139. doi: 10.2196/40139. PMID: 36520509.
- Struble CA, Borodovsky JT, Habib MI, Hasin DS, Shmulewitz D, Livne O, Walsh C, Aharonovich E, Budney AJ. Cannabis practices among a gender-diverse sample of young adults. Drug Alcohol Depend Rep. 2022 Dec;5:100113. doi: 10.1016/j.dadr.2022.100113. PMID: 36741544; PMCID: PMC9894216.
- Sofis MJ, Lemley SM, Jacobson NC, Budney AJ. Initial evaluation of domain-specific episodic future thinking on delay discounting and cannabis use. Exp Clin Psychopharmacol. 2022 Dec;30(6):918-927. doi: 10.1037/pha0000501. PMID: 34096759; PMCID: PMC9214768.
- Goodwin RD, Shevorykin A, Carl E, Budney AJ, Rivard C, Wu M, McClure EA, Hyland A, Sheffer CE. Daily cannabis use is a barrier to tobacco cessation among tobacco Quitline callers at 7-month follow-up. Nicotine Tob Res. 2022 Oct 17;24(10):1684-1688. doi: 10.1093/ntr/ntac096. PMID: 35417562.
- Livne O, Budney A, Borodovsky J, Walsh C, Shmulewitz D, Fink DS, Struble CA, Habib M, Aharonovich E, Hasin DS. Delta-8 THC use in US adults: Sociodemographic characteristics and correlates. Addict Behav. 2022 Oct;133:107374. doi: 10.1016/j.addbeh.2022.107374. PMID: 35644057; PMCID: PMC9245337.
- Keller OC, Budney AJ, Struble CA, Teepe GW. Blending digital therapeutics within the healthcare system. In Jacobson N, Kowatsch T, Marsch LA, editors. Digital therapeutics for mental health and addiction: The state of the science and vision for the future. Academic Press; 2022 September 27. Chapter 5. Paperback ISBN: 9780323900454.
- Sherman BJ, Sofis MJ, Borodovsky JT, Gray KM, McRae-Clark AL, Budney AJ. Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder. Psychol Addict Behav. 2022 Aug;36(5):505-514. doi: 10.1037/adb0000760. PMID: 34197135; PMCID: PMC8720114.
- Borodovsky JT, Sofis MJ, Sherman BJ, Gray KM, Budney AJ. Characterizing cannabis use reduction and change in functioning during treatment: Initial steps on the path to new clinical endpoints. Psychol Addict Behav. 2022 Aug;36(5):515-525. doi: 10.1037/adb0000817. PMID: 35084903; PMCID: PMC9325921.